Ignite Creation Date:
2024-05-06 @ 12:16 AM
Last Modification Date:
2024-10-26 @ 10:47 AM
Study NCT ID:
NCT01534260
Status:
COMPLETED
Last Update Posted:
2018-08-17
First Post:
2012-02-13
Brief Title:
Phase III Study of Combination of Sorafenib Vorinostat and Bortezomib for the Treatment of Acute Myeloid Leukemia With Complex- or Poor-risk Monosomy 57 Cytogenetics or FLT3-ITD Positive Genotype
Sponsor:
Hamid Sayar
Organization:
Indiana University
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-02-10
Start Date Type:
ACTUAL
Primary Completion Date:
2016-08-29
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-02-13
Completion Date Type:
ACTUAL
First Submit Date:
2012-02-13
First Submit QC Date:
February 15 2012
Study First Post Date:
2012-02-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2018-08-17
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-07-20
Last Update Post Date:
2018-08-17
Last Update Post Date Type:
ACTUAL